Loading...
Market
Will Riverlane announce a major partnership with a pharmaceutical company by the end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from Riverlane or the partnering pharmaceutical company
Story
Riverlane Raises $75M in Series C at $400M Valuation to Advance Quantum Error Correction Technology
Aug 6, 2024, 07:18 AM
UK-based quantum computing company Riverlane has raised $75 million in Series C funding to advance its quantum error correction technology. The funding round was led by Planet First Partners, with participation from ETF Partners, EDBI, CIC, Amadeus Capital, NSSIF, and Altair. Riverlane, headquartered in Cambridge, aims to develop its next-generation chip and achieve 1 million error-free quantum operations by 2026. The company, which also makes semiconductors, is valued at $400 million following this latest funding round. The investment is expected to support further discoveries in pharmaceuticals, chemicals, material science, and transportation.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
